Table 3 Cardiovascular mortality in patients with and without DM in different patients subgroups
From: Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic
| Factor present | ||||||
|---|---|---|---|---|---|---|
| Yes | No | |||||
| DM | Non-DM | P value | DM | Non-DM | P value | |
| Age > 80 (%) | 4.6 | 1.9 | 0.093 | 1.0 | 0.0 | 0.003 |
| Female gender (%) | 4.1 | 0.5 | 0.001 | 0.7 | 0.3 | 0.409 |
| Hypertension (%) | 2.3 | 0.5 | 0.002 | 0.0 | 0.2 | 1.000 |
| Hypercholesterolemia (%) | 2.0 | 0.6 | 0.023 | 1.5 | 0.1 | 0.032 |
| Smoking (%) | 0.5 | 0.0 | 0.335 | 2.3 | 0.5 | 0.002 |
| Chronic renal failure (%) | 7.7 | 1.9 | 0.083 | 1.0 | 0.3 | 0.079 |
| Peripheral artery disease (%) | 0.0 | 0.0 | 1.000 | 2.2 | 0.5 | < 0.001 |
| Previous CAD (%) | 1.4 | 0.5 | 0.244 | 2.3 | 0.4 | 0.002 |
| Previous infarction (%) | 0.8 | 0.6 | 1.000 | 2.1 | 0.4 | < 0.001 |
| Previous PCI (%) | 1.8 | 0.4 | 0.312 | 1.9 | 0.4 | 0.004 |
| Previous CABG (%) | 0.0 | 2.1 | 1.000 | 2.0 | 0.4 | < 0.001 |
| Previous valve replacement (%) | 4.3 | 0.0 | 0.253 | 1.7 | 0.4 | 0.002 |
| Left ventricular dysfunction (%) | 1.1 | 0.7 | 0.635 | 2.2 | 0.4 | 0.001 |
| NYHA > 2 (%) | 5.1 | 1.2 | 0.049 | 1.6 | 0.2 | 0.004 |
| CCS > 2 (%) | 3.2 | 2.9 | 1.000 | 1.8 | 0.2 | < 0.001 |